Inhibition of invasion and capillary-like tube formation by retrohydroxamate-based MMP inhibitors

Seung Su Choi, Ae Ri Ji, Seung Woo Yu, Bong Hwan Cho, Jung Dae Park, Jun Hyoung Park, Hyun Soo Lee, Seong Eon Ryu, Dong Han Kim, Jae Hoon Kang, Seung Taek Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Matrix metalloproteinases (MMPs), a family of zinc-containing endopeptidases, participate in many normal processes such as embryonic development and wound repair, and in many pathological situations such as cancer, atherosclerosis, and arthritis. Peptidomimetic MMP inhibitors were designed and synthesized with Nformylhydroxylamine (retrohydroxamate) as a zinc-binding group and various side chains on the α, P1′, and P2′ positions. Using in vitro MMP assays with purified MMPs (MMP-1, MMP-2, MMP-3, MMP-9, and MMP-14) and fluorogenic peptide substrates, it was found that compounds 2d and 2g selectively inhibit gelatinases (MMP-2 and MMP-9) and interstitial collagenase (MMP-1). They also inhibited the chemo-invasion of fibrosarcoma HT-1080 cells and tube formation of human umbilical vascular endothelial cells in a dosedependent manner. Our results suggest that retrohydroxamate-based MMP inhibitors, especially compounds 2d and 2g, have the potential to be used as therapeutic drugs for cancer and other MMP-related diseases.

Original languageEnglish
Pages (from-to)2032-2038
Number of pages7
JournalBulletin of the Korean Chemical Society
Volume32
Issue number6
DOIs
Publication statusPublished - 2011 Jun 20

Fingerprint

Matrix Metalloproteinase Inhibitors
Matrix Metalloproteinases
Matrix Metalloproteinase 1
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Zinc
Matrix Metalloproteinase 14
Peptidomimetics
Matrix Metalloproteinase 3
Gelatinases
Endopeptidases
Endothelial cells
Assays
Repair
Peptides
Substrates
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Chemistry(all)

Cite this

Choi, Seung Su ; Ji, Ae Ri ; Yu, Seung Woo ; Cho, Bong Hwan ; Park, Jung Dae ; Park, Jun Hyoung ; Lee, Hyun Soo ; Ryu, Seong Eon ; Kim, Dong Han ; Kang, Jae Hoon ; Lee, Seung Taek. / Inhibition of invasion and capillary-like tube formation by retrohydroxamate-based MMP inhibitors. In: Bulletin of the Korean Chemical Society. 2011 ; Vol. 32, No. 6. pp. 2032-2038.
@article{7ec5538b7f594229949701c8c2aabdf2,
title = "Inhibition of invasion and capillary-like tube formation by retrohydroxamate-based MMP inhibitors",
abstract = "Matrix metalloproteinases (MMPs), a family of zinc-containing endopeptidases, participate in many normal processes such as embryonic development and wound repair, and in many pathological situations such as cancer, atherosclerosis, and arthritis. Peptidomimetic MMP inhibitors were designed and synthesized with Nformylhydroxylamine (retrohydroxamate) as a zinc-binding group and various side chains on the α, P1′, and P2′ positions. Using in vitro MMP assays with purified MMPs (MMP-1, MMP-2, MMP-3, MMP-9, and MMP-14) and fluorogenic peptide substrates, it was found that compounds 2d and 2g selectively inhibit gelatinases (MMP-2 and MMP-9) and interstitial collagenase (MMP-1). They also inhibited the chemo-invasion of fibrosarcoma HT-1080 cells and tube formation of human umbilical vascular endothelial cells in a dosedependent manner. Our results suggest that retrohydroxamate-based MMP inhibitors, especially compounds 2d and 2g, have the potential to be used as therapeutic drugs for cancer and other MMP-related diseases.",
author = "Choi, {Seung Su} and Ji, {Ae Ri} and Yu, {Seung Woo} and Cho, {Bong Hwan} and Park, {Jung Dae} and Park, {Jun Hyoung} and Lee, {Hyun Soo} and Ryu, {Seong Eon} and Kim, {Dong Han} and Kang, {Jae Hoon} and Lee, {Seung Taek}",
year = "2011",
month = "6",
day = "20",
doi = "10.5012/bkcs.2011.32.6.2032",
language = "English",
volume = "32",
pages = "2032--2038",
journal = "Bulletin of the Korean Chemical Society",
issn = "0253-2964",
publisher = "Korean Chemical Society",
number = "6",

}

Choi, SS, Ji, AR, Yu, SW, Cho, BH, Park, JD, Park, JH, Lee, HS, Ryu, SE, Kim, DH, Kang, JH & Lee, ST 2011, 'Inhibition of invasion and capillary-like tube formation by retrohydroxamate-based MMP inhibitors', Bulletin of the Korean Chemical Society, vol. 32, no. 6, pp. 2032-2038. https://doi.org/10.5012/bkcs.2011.32.6.2032

Inhibition of invasion and capillary-like tube formation by retrohydroxamate-based MMP inhibitors. / Choi, Seung Su; Ji, Ae Ri; Yu, Seung Woo; Cho, Bong Hwan; Park, Jung Dae; Park, Jun Hyoung; Lee, Hyun Soo; Ryu, Seong Eon; Kim, Dong Han; Kang, Jae Hoon; Lee, Seung Taek.

In: Bulletin of the Korean Chemical Society, Vol. 32, No. 6, 20.06.2011, p. 2032-2038.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inhibition of invasion and capillary-like tube formation by retrohydroxamate-based MMP inhibitors

AU - Choi, Seung Su

AU - Ji, Ae Ri

AU - Yu, Seung Woo

AU - Cho, Bong Hwan

AU - Park, Jung Dae

AU - Park, Jun Hyoung

AU - Lee, Hyun Soo

AU - Ryu, Seong Eon

AU - Kim, Dong Han

AU - Kang, Jae Hoon

AU - Lee, Seung Taek

PY - 2011/6/20

Y1 - 2011/6/20

N2 - Matrix metalloproteinases (MMPs), a family of zinc-containing endopeptidases, participate in many normal processes such as embryonic development and wound repair, and in many pathological situations such as cancer, atherosclerosis, and arthritis. Peptidomimetic MMP inhibitors were designed and synthesized with Nformylhydroxylamine (retrohydroxamate) as a zinc-binding group and various side chains on the α, P1′, and P2′ positions. Using in vitro MMP assays with purified MMPs (MMP-1, MMP-2, MMP-3, MMP-9, and MMP-14) and fluorogenic peptide substrates, it was found that compounds 2d and 2g selectively inhibit gelatinases (MMP-2 and MMP-9) and interstitial collagenase (MMP-1). They also inhibited the chemo-invasion of fibrosarcoma HT-1080 cells and tube formation of human umbilical vascular endothelial cells in a dosedependent manner. Our results suggest that retrohydroxamate-based MMP inhibitors, especially compounds 2d and 2g, have the potential to be used as therapeutic drugs for cancer and other MMP-related diseases.

AB - Matrix metalloproteinases (MMPs), a family of zinc-containing endopeptidases, participate in many normal processes such as embryonic development and wound repair, and in many pathological situations such as cancer, atherosclerosis, and arthritis. Peptidomimetic MMP inhibitors were designed and synthesized with Nformylhydroxylamine (retrohydroxamate) as a zinc-binding group and various side chains on the α, P1′, and P2′ positions. Using in vitro MMP assays with purified MMPs (MMP-1, MMP-2, MMP-3, MMP-9, and MMP-14) and fluorogenic peptide substrates, it was found that compounds 2d and 2g selectively inhibit gelatinases (MMP-2 and MMP-9) and interstitial collagenase (MMP-1). They also inhibited the chemo-invasion of fibrosarcoma HT-1080 cells and tube formation of human umbilical vascular endothelial cells in a dosedependent manner. Our results suggest that retrohydroxamate-based MMP inhibitors, especially compounds 2d and 2g, have the potential to be used as therapeutic drugs for cancer and other MMP-related diseases.

UR - http://www.scopus.com/inward/record.url?scp=79959413927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959413927&partnerID=8YFLogxK

U2 - 10.5012/bkcs.2011.32.6.2032

DO - 10.5012/bkcs.2011.32.6.2032

M3 - Article

AN - SCOPUS:79959413927

VL - 32

SP - 2032

EP - 2038

JO - Bulletin of the Korean Chemical Society

JF - Bulletin of the Korean Chemical Society

SN - 0253-2964

IS - 6

ER -